News
![Non-alcoholic_fatty_liver_disease1](https://pharmaphorum.com/wp-content/uploads/2020/05/Non-alcoholic_fatty_liver_disease1.jpg)
Digital health firm ChronWell raises $6m for liver disease t...
US remote healthcare specialist ChronWell has raised $6 million from investors that will be used to accelerate the rollout of its patient management programmes for people with liver and gas